Authors


Rajasekhar Jaladi, PhD

Latest:

Assessment of Nanosuspension Formulation for Intranasal Administration

Research suggests that intranasal nanosuspensions offer a promising way to formulate and deliver drugs that are poorly soluble in water to patients with chronic conditions.


Jennifer Putnam

Latest:

Mitigating the Risk from Excipient Variability

This article reviews sources of excipient variability, including raw materials and processing, both of which may vary from supplier to supplier and from plant to plant for a single manufacturer.


Klaus Lindpaintner

Latest:

Using Novel Biomarkers to Facilitate AI-Driven Glycoproteomics

With the evolution of scalability of peripheral blood protein glycosylation, research has expanded for new biomarkers.



John Lewis

Latest:

Risks and Rewards of Investing in RNA-based Genetic Medicine Manufacturing

Collaboration is a key component to achieving long-term success with genetic medicines.


CPHI Content Team

Latest:

Innovative Start-Ups at CPHI Barcelona

The Start-Up Market at CPHI Barcelona will bring together 27 start-ups, innovators, and small enterprises from across the pharma landscape.


Veolia

Latest:

Mitigating Pharmaceutical Production Risks Using Hot Water for Injection and Pure Steam

Webinar Date/Time: Wed, Feb 7, 2024 10:30 AM CET (4:30 AM EST)



Luke Hamm

Latest:

Continued Innovation is Key for COVID-19 Recovery

More work is needed to educate businesses on the value of innovation and the availability of funding.



Zhiping Yao

Latest:

Current Trends in Host Cell Protein Detection for Biologics Manufacturing

In this paper, the authors lay out some commonly accepted HCP analytical methods, the challenges of HCP assay, and provide recommendations on what can easily be accomplished in-house and when it may be better to outsource.


George Hartford

Latest:

Effective and Efficient Weighing of Potent Compounds

The advantages of using an automated powder dispensing system in a ventilated balance enclosure for efficient handling and effective containment of potent compounds are discussed.


Jonathan Fura

Latest:

A Novel Cell Lysis Method to Improve the Viral Vector Manufacturing Process

Researchers demonstrated a new cell lysis method using a novel solution to improve viral vector production.




IMA Active

Latest:

The potential of CROMA continuous coater

CROMA continuous coater brings an innovative technological progress in manufacturing based on modularity and truly continuous film coating of tables.


Ashley Boam

Latest:

The Global Regulatory Village

Harmonization of global regulations fosters innovation and ensures quality medicines.


Anthony J. Sinskey

Latest:

The Impact of SARS-CoV-2 on Biomanufacturing Operations

This article presents the results of a survey conducted to gain insight on the impact of the COVID-19 pandemic on biomanufacturing operations.


Jorie Kassel

Latest:

Using Image Analysis to Differentiate Particle Size and Shape in Drug Products with Multiple Components

Image analysis is crucial for particle analysis of complex finished drug products.


Adam Goulder

Latest:

Why Are Pharmaceutical Companies Reluctant to Adopt Cloud Technologies?

Despite its understandable hesitancy, the pharma industry is facing a need for more widespread adoption of cloud-based solutions.


Xiaohong Bei

Latest:

Highly Efficient Olefin-Metathesis Catalysts

The authors describe the Piers' catalysts and detail latest progress in olefin-metathesis catalyst technology.


Holly Lombardo

Latest:

Improving IR Spectroscopy as a Tool for Biopharmaceutical Analysis

A recent innovation in infrared spectroscopy, Microfluidic Modulation Spectroscopy has been shown to improve characterization of secondary protein structure.


David Schoneker

Latest:

Understanding Excipient Characteristics to Ensure Robust Continuous Manufacturing

Key information is needed for excipients and their potential impact on continuous manufacturing processes.


Huub Schellekens

Latest:

What Is Hindering The Uptake Of Biosimilars?

The biggest differences between the development of a biosimilar and a generic medicine lie primarily in the preclinical and clinical stages.


João Ventura

Latest:

Spray Drying as an Enabling Technology for Inhalation Drug Delivery

Particle performance in a DPI can be optimized by fine-tuning the formulation and manufacturing process parameters.


Brandon J. Bills

Latest:

Advancing Detection of Unknown Impurities

Having intelligent analytical tools can advance the detection of unknown impurities, which is important for ensuring small-molecule ingredient purity.


Mark Eller

Latest:

Technology as a New Evolution in Fighting Disease

Advancing the use of AI to understand the whole of a disease can reveal drug development insights that lead to drug discovery breakthroughs.


Oliver Excell

Latest:

Overcoming Engineering Challenges to Enable Commercial Scale mRNA Vaccine Manufacturing

This article provides an overview of solutions to address key challenges facing vaccine developers or CDMOs wishing to build their own commercial-scale mRNA production facilities.


Michael E. Wiebe

Latest:

The Impact of SARS-CoV-2 on Biomanufacturing Operations

This article presents the results of a survey conducted to gain insight on the impact of the COVID-19 pandemic on biomanufacturing operations.


Paul Smith

Latest:

Use Of RFID Asset Management Systems For Monitoring Analytical Instrumentation

Utilizing integrated active radio frequency identification (RFID) and real-time asset management systems can yield commercial and compliance benefits.

© 2025 MJH Life Sciences

All rights reserved.